UniProt ID | TXLNA_HUMAN | |
---|---|---|
UniProt AC | P40222 | |
Protein Name | Alpha-taxilin | |
Gene Name | TXLNA | |
Organism | Homo sapiens (Human). | |
Sequence Length | 546 | |
Subcellular Localization | ||
Protein Description | May be involved in intracellular vesicle traffic and potentially in calcium-dependent exocytosis in neuroendocrine cells.. | |
Protein Sequence | MKNQDKKNGAAKQSNPKSSPGQPEAGPEGAQERPSQAAPAVEAEGPGSSQAPRKPEGAQARTAQSGALRDVSEELSRQLEDILSTYCVDNNQGGPGEDGAQGEPAEPEDAEKSRTYVARNGEPEPTPVVNGEKEPSKGDPNTEEIRQSDEVGDRDHRRPQEKKKAKGLGKEITLLMQTLNTLSTPEEKLAALCKKYAELLEEHRNSQKQMKLLQKKQSQLVQEKDHLRGEHSKAVLARSKLESLCRELQRHNRSLKEEGVQRAREEEEKRKEVTSHFQVTLNDIQLQMEQHNERNSKLRQENMELAERLKKLIEQYELREEHIDKVFKHKDLQQQLVDAKLQQAQEMLKEAEERHQREKDFLLKEAVESQRMCELMKQQETHLKQQLALYTEKFEEFQNTLSKSSEVFTTFKQEMEKMTKKIKKLEKETTMYRSRWESSNKALLEMAEEKTVRDKELEGLQVKIQRLEKLCRALQTERNDLNKRVQDLSAGGQGSLTDSGPERRPEGPGAQAPSSPRVTEAPCYPGAPSTEASGQTGPQEPTSARA | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
14 | Phosphorylation | KNGAAKQSNPKSSPG CCCCCCCCCCCCCCC | 55.16 | 28464451 | |
18 | Phosphorylation | AKQSNPKSSPGQPEA CCCCCCCCCCCCCCC | 42.92 | 25159151 | |
19 | Phosphorylation | KQSNPKSSPGQPEAG CCCCCCCCCCCCCCC | 38.89 | 25159151 | |
19 | Ubiquitination | KQSNPKSSPGQPEAG CCCCCCCCCCCCCCC | 38.89 | 33845483 | |
33 | Ubiquitination | GPEGAQERPSQAAPA CCCCCCCCCCCCCCC | 24.88 | 32015554 | |
35 | Phosphorylation | EGAQERPSQAAPAVE CCCCCCCCCCCCCCC | 38.38 | 30278072 | |
48 | Phosphorylation | VEAEGPGSSQAPRKP CCCCCCCCCCCCCCC | 23.55 | 23927012 | |
49 | Phosphorylation | EAEGPGSSQAPRKPE CCCCCCCCCCCCCCC | 35.96 | 24732914 | |
49 | Ubiquitination | EAEGPGSSQAPRKPE CCCCCCCCCCCCCCC | 35.96 | 32015554 | |
54 | Ubiquitination | GSSQAPRKPEGAQAR CCCCCCCCCCCCHHH | 46.49 | 29967540 | |
58 | Ubiquitination | APRKPEGAQARTAQS CCCCCCCCHHHHHHC | 9.74 | 33845483 | |
65 | Phosphorylation | AQARTAQSGALRDVS CHHHHHHCCHHHHHH | 24.46 | 23917254 | |
65 | Ubiquitination | AQARTAQSGALRDVS CHHHHHHCCHHHHHH | 24.46 | 23000965 | |
69 | Methylation | TAQSGALRDVSEELS HHHCCHHHHHHHHHH | 41.57 | 115919189 | |
72 | Phosphorylation | SGALRDVSEELSRQL CCHHHHHHHHHHHHH | 29.64 | 21815630 | |
80 | Ubiquitination | EELSRQLEDILSTYC HHHHHHHHHHHHHHC | 34.37 | 23000965 | |
81 | Ubiquitination | ELSRQLEDILSTYCV HHHHHHHHHHHHHCC | 56.58 | 33845483 | |
84 | Phosphorylation | RQLEDILSTYCVDNN HHHHHHHHHHCCCCC | 20.05 | 29978859 | |
85 | Phosphorylation | QLEDILSTYCVDNNQ HHHHHHHHHCCCCCC | 19.93 | 29978859 | |
86 | Phosphorylation | LEDILSTYCVDNNQG HHHHHHHHCCCCCCC | 6.26 | 22817900 | |
96 | Ubiquitination | DNNQGGPGEDGAQGE CCCCCCCCCCCCCCC | 49.23 | 24816145 | |
113 | Phosphorylation | EPEDAEKSRTYVARN CHHHHHHHCCEECCC | 22.74 | 21712546 | |
135 | Ubiquitination | VVNGEKEPSKGDPNT CCCCCCCCCCCCCCH | 53.03 | 23000965 | |
136 | Ubiquitination | VNGEKEPSKGDPNTE CCCCCCCCCCCCCHH | 50.81 | 23000965 | |
137 | Ubiquitination | NGEKEPSKGDPNTEE CCCCCCCCCCCCHHH | 77.40 | 24816145 | |
142 | Phosphorylation | PSKGDPNTEEIRQSD CCCCCCCHHHHHCCC | 40.14 | 21815630 | |
146 | Methylation | DPNTEEIRQSDEVGD CCCHHHHHCCCCCCC | 32.98 | 115919181 | |
148 | Phosphorylation | NTEEIRQSDEVGDRD CHHHHHCCCCCCCCC | 26.37 | 30576142 | |
150 | Ubiquitination | EEIRQSDEVGDRDHR HHHHCCCCCCCCCCC | 54.36 | 23000965 | |
151 | Ubiquitination | EIRQSDEVGDRDHRR HHHCCCCCCCCCCCC | 13.34 | 23000965 | |
155 | Ubiquitination | SDEVGDRDHRRPQEK CCCCCCCCCCCHHHH | 44.37 | 33845483 | |
165 | Ubiquitination | RPQEKKKAKGLGKEI CHHHHHHHCCCHHHH | 21.74 | 32015554 | |
170 | Ubiquitination | KKAKGLGKEITLLMQ HHHCCCHHHHHHHHH | 51.49 | 29967540 | |
174 | Ubiquitination | GLGKEITLLMQTLNT CCHHHHHHHHHHHHH | 4.62 | 32015554 | |
189 | Ubiquitination | LSTPEEKLAALCKKY CCCHHHHHHHHHHHH | 3.69 | 33845483 | |
194 | 2-Hydroxyisobutyrylation | EKLAALCKKYAELLE HHHHHHHHHHHHHHH | 50.06 | - | |
194 | Acetylation | EKLAALCKKYAELLE HHHHHHHHHHHHHHH | 50.06 | 25953088 | |
194 | Ubiquitination | EKLAALCKKYAELLE HHHHHHHHHHHHHHH | 50.06 | 33845483 | |
195 | 2-Hydroxyisobutyrylation | KLAALCKKYAELLEE HHHHHHHHHHHHHHH | 49.01 | - | |
195 | Acetylation | KLAALCKKYAELLEE HHHHHHHHHHHHHHH | 49.01 | 26051181 | |
195 | Ubiquitination | KLAALCKKYAELLEE HHHHHHHHHHHHHHH | 49.01 | - | |
196 | Phosphorylation | LAALCKKYAELLEEH HHHHHHHHHHHHHHH | 7.27 | 25907765 | |
202 | Ubiquitination | KYAELLEEHRNSQKQ HHHHHHHHHHCHHHH | 48.38 | 32015554 | |
204 | Ubiquitination | AELLEEHRNSQKQMK HHHHHHHHCHHHHHH | 48.01 | 24816145 | |
206 | Phosphorylation | LLEEHRNSQKQMKLL HHHHHHCHHHHHHHH | 38.42 | 25907765 | |
211 | Acetylation | RNSQKQMKLLQKKQS HCHHHHHHHHHHHHH | 43.48 | 25953088 | |
211 | Malonylation | RNSQKQMKLLQKKQS HCHHHHHHHHHHHHH | 43.48 | 30639696 | |
216 | Ubiquitination | QMKLLQKKQSQLVQE HHHHHHHHHHHHHHH | 42.07 | 29967540 | |
218 | Phosphorylation | KLLQKKQSQLVQEKD HHHHHHHHHHHHHHH | 34.07 | 27282143 | |
218 | Ubiquitination | KLLQKKQSQLVQEKD HHHHHHHHHHHHHHH | 34.07 | 32015554 | |
224 | Acetylation | QSQLVQEKDHLRGEH HHHHHHHHHHHCCHH | 33.10 | 27452117 | |
224 | Ubiquitination | QSQLVQEKDHLRGEH HHHHHHHHHHHCCHH | 33.10 | 32015554 | |
228 | Ubiquitination | VQEKDHLRGEHSKAV HHHHHHHCCHHHHHH | 45.06 | 21890473 | |
232 | Phosphorylation | DHLRGEHSKAVLARS HHHCCHHHHHHHHHH | 20.29 | - | |
233 | 2-Hydroxyisobutyrylation | HLRGEHSKAVLARSK HHCCHHHHHHHHHHH | 44.41 | - | |
233 | Ubiquitination | HLRGEHSKAVLARSK HHCCHHHHHHHHHHH | 44.41 | 33845483 | |
237 | Ubiquitination | EHSKAVLARSKLESL HHHHHHHHHHHHHHH | 13.70 | 32015554 | |
240 | Acetylation | KAVLARSKLESLCRE HHHHHHHHHHHHHHH | 51.20 | 25953088 | |
240 | Ubiquitination | KAVLARSKLESLCRE HHHHHHHHHHHHHHH | 51.20 | 23000965 | |
243 | Phosphorylation | LARSKLESLCRELQR HHHHHHHHHHHHHHH | 43.11 | 24719451 | |
243 | Ubiquitination | LARSKLESLCRELQR HHHHHHHHHHHHHHH | 43.11 | 21890473 | |
245 | Glutathionylation | RSKLESLCRELQRHN HHHHHHHHHHHHHHC | 4.41 | 22555962 | |
246 | Ubiquitination | SKLESLCRELQRHNR HHHHHHHHHHHHHCH | 53.61 | 23000965 | |
248 | Ubiquitination | LESLCRELQRHNRSL HHHHHHHHHHHCHHH | 2.54 | 23000965 | |
249 | Ubiquitination | ESLCRELQRHNRSLK HHHHHHHHHHCHHHH | 39.57 | 23000965 | |
252 | Ubiquitination | CRELQRHNRSLKEEG HHHHHHHCHHHHHHH | 37.11 | 23000965 | |
254 | Phosphorylation | ELQRHNRSLKEEGVQ HHHHHCHHHHHHHHH | 49.46 | 28857561 | |
256 | 2-Hydroxyisobutyrylation | QRHNRSLKEEGVQRA HHHCHHHHHHHHHHH | 55.77 | - | |
256 | Acetylation | QRHNRSLKEEGVQRA HHHCHHHHHHHHHHH | 55.77 | 26051181 | |
256 | Ubiquitination | QRHNRSLKEEGVQRA HHHCHHHHHHHHHHH | 55.77 | 24816145 | |
261 | Ubiquitination | SLKEEGVQRAREEEE HHHHHHHHHHHHHHH | 44.14 | 23000965 | |
263 | Ubiquitination | KEEGVQRAREEEEKR HHHHHHHHHHHHHHH | 13.22 | 23000965 | |
264 | Ubiquitination | EEGVQRAREEEEKRK HHHHHHHHHHHHHHH | 54.79 | 23000965 | |
267 | Ubiquitination | VQRAREEEEKRKEVT HHHHHHHHHHHHHHH | 65.15 | 23000965 | |
273 | Ubiquitination | EEEKRKEVTSHFQVT HHHHHHHHHHHHEEH | 8.15 | 23000965 | |
280 | Ubiquitination | VTSHFQVTLNDIQLQ HHHHHEEHHHHHHHH | 14.73 | 24816145 | |
289 | Ubiquitination | NDIQLQMEQHNERNS HHHHHHHHHHHHHHH | 35.41 | 24816145 | |
295 | Ubiquitination | MEQHNERNSKLRQEN HHHHHHHHHHHHHHH | 37.00 | 24816145 | |
303 | Sulfoxidation | SKLRQENMELAERLK HHHHHHHHHHHHHHH | 4.37 | 21406390 | |
308 | Methylation | ENMELAERLKKLIEQ HHHHHHHHHHHHHHH | 46.32 | 115919185 | |
310 | Ubiquitination | MELAERLKKLIEQYE HHHHHHHHHHHHHHH | 52.32 | 23000965 | |
311 | Acetylation | ELAERLKKLIEQYEL HHHHHHHHHHHHHHH | 60.33 | 24885699 | |
311 | Ubiquitination | ELAERLKKLIEQYEL HHHHHHHHHHHHHHH | 60.33 | 23000965 | |
325 | 2-Hydroxyisobutyrylation | LREEHIDKVFKHKDL HHHHHHHHHHCCHHH | 49.30 | - | |
325 | Acetylation | LREEHIDKVFKHKDL HHHHHHHHHHCCHHH | 49.30 | 23236377 | |
325 | Ubiquitination | LREEHIDKVFKHKDL HHHHHHHHHHCCHHH | 49.30 | - | |
330 | Ubiquitination | IDKVFKHKDLQQQLV HHHHHCCHHHHHHHH | 61.80 | 33845483 | |
340 | 2-Hydroxyisobutyrylation | QQQLVDAKLQQAQEM HHHHHHHHHHHHHHH | 42.22 | - | |
340 | Acetylation | QQQLVDAKLQQAQEM HHHHHHHHHHHHHHH | 42.22 | 27452117 | |
340 | Phosphorylation | QQQLVDAKLQQAQEM HHHHHHHHHHHHHHH | 42.22 | 33259812 | |
340 | Ubiquitination | QQQLVDAKLQQAQEM HHHHHHHHHHHHHHH | 42.22 | 32015554 | |
343 | Ubiquitination | LVDAKLQQAQEMLKE HHHHHHHHHHHHHHH | 56.29 | 23000965 | |
344 | Ubiquitination | VDAKLQQAQEMLKEA HHHHHHHHHHHHHHH | 8.37 | 23000965 | |
347 | Sulfoxidation | KLQQAQEMLKEAEER HHHHHHHHHHHHHHH | 4.27 | 21406390 | |
349 | Ubiquitination | QQAQEMLKEAEERHQ HHHHHHHHHHHHHHH | 54.27 | 32015554 | |
364 | Ubiquitination | REKDFLLKEAVESQR HHHHHHHHHHHHHHH | 45.86 | 32015554 | |
377 | Acetylation | QRMCELMKQQETHLK HHHHHHHHHHHHHHH | 62.55 | 25953088 | |
377 | Ubiquitination | QRMCELMKQQETHLK HHHHHHHHHHHHHHH | 62.55 | 32015554 | |
393 | Acetylation | QLALYTEKFEEFQNT HHHHHHHHHHHHHHH | 50.72 | 26051181 | |
393 | Ubiquitination | QLALYTEKFEEFQNT HHHHHHHHHHHHHHH | 50.72 | 32015554 | |
397 | Ubiquitination | YTEKFEEFQNTLSKS HHHHHHHHHHHHHHC | 5.52 | 24816145 | |
403 | Ubiquitination | EFQNTLSKSSEVFTT HHHHHHHHCHHHHHH | 62.20 | 21906983 | |
412 | Acetylation | SEVFTTFKQEMEKMT HHHHHHHHHHHHHHH | 43.17 | 26822725 | |
412 | Ubiquitination | SEVFTTFKQEMEKMT HHHHHHHHHHHHHHH | 43.17 | 32015554 | |
419 | Phosphorylation | KQEMEKMTKKIKKLE HHHHHHHHHHHHHHH | 40.01 | 22817900 | |
421 | Acetylation | EMEKMTKKIKKLEKE HHHHHHHHHHHHHHH | 51.06 | 12436313 | |
421 | Ubiquitination | EMEKMTKKIKKLEKE HHHHHHHHHHHHHHH | 51.06 | 23000965 | |
423 | Ubiquitination | EKMTKKIKKLEKETT HHHHHHHHHHHHHHH | 61.25 | 23000965 | |
424 | Ubiquitination | KMTKKIKKLEKETTM HHHHHHHHHHHHHHH | 66.41 | 23000965 | |
427 | Acetylation | KKIKKLEKETTMYRS HHHHHHHHHHHHHHH | 71.45 | 25953088 | |
427 | Ubiquitination | KKIKKLEKETTMYRS HHHHHHHHHHHHHHH | 71.45 | 23000965 | |
436 | Ubiquitination | TTMYRSRWESSNKAL HHHHHHHHHHHHHHH | 15.86 | 21890473 | |
441 | Ubiquitination | SRWESSNKALLEMAE HHHHHHHHHHHHHHH | 42.21 | 29967540 | |
451 | Phosphorylation | LEMAEEKTVRDKELE HHHHHHHCCCHHHHH | 24.85 | 27135362 | |
454 | Ubiquitination | AEEKTVRDKELEGLQ HHHHCCCHHHHHHHH | 44.43 | 23000965 | |
455 | 2-Hydroxyisobutyrylation | EEKTVRDKELEGLQV HHHCCCHHHHHHHHH | 54.34 | - | |
455 | Acetylation | EEKTVRDKELEGLQV HHHCCCHHHHHHHHH | 54.34 | 25953088 | |
455 | Ubiquitination | EEKTVRDKELEGLQV HHHCCCHHHHHHHHH | 54.34 | 24816145 | |
456 | Ubiquitination | EKTVRDKELEGLQVK HHCCCHHHHHHHHHH | 57.24 | 23000965 | |
457 | Ubiquitination | KTVRDKELEGLQVKI HCCCHHHHHHHHHHH | 8.56 | 23000965 | |
460 | Ubiquitination | RDKELEGLQVKIQRL CHHHHHHHHHHHHHH | 3.75 | 23000965 | |
463 | 2-Hydroxyisobutyrylation | ELEGLQVKIQRLEKL HHHHHHHHHHHHHHH | 21.84 | - | |
463 | Acetylation | ELEGLQVKIQRLEKL HHHHHHHHHHHHHHH | 21.84 | 25953088 | |
463 | Ubiquitination | ELEGLQVKIQRLEKL HHHHHHHHHHHHHHH | 21.84 | 29967540 | |
469 | Acetylation | VKIQRLEKLCRALQT HHHHHHHHHHHHHHH | 58.44 | 26051181 | |
488 | Ubiquitination | LNKRVQDLSAGGQGS HHHHHHHHHCCCCCC | 1.80 | 24816145 | |
489 | Phosphorylation | NKRVQDLSAGGQGSL HHHHHHHHCCCCCCC | 32.91 | 28152594 | |
495 | Phosphorylation | LSAGGQGSLTDSGPE HHCCCCCCCCCCCCC | 21.87 | 25159151 | |
497 | Phosphorylation | AGGQGSLTDSGPERR CCCCCCCCCCCCCCC | 29.80 | 25159151 | |
499 | Phosphorylation | GQGSLTDSGPERRPE CCCCCCCCCCCCCCC | 51.52 | 21082442 | |
514 | Phosphorylation | GPGAQAPSSPRVTEA CCCCCCCCCCCCCCC | 56.86 | 29255136 | |
515 | Phosphorylation | PGAQAPSSPRVTEAP CCCCCCCCCCCCCCC | 18.70 | 29255136 | |
519 | O-linked_Glycosylation | APSSPRVTEAPCYPG CCCCCCCCCCCCCCC | 27.92 | 23301498 | |
519 | Phosphorylation | APSSPRVTEAPCYPG CCCCCCCCCCCCCCC | 27.92 | 25159151 | |
523 | Glutathionylation | PRVTEAPCYPGAPST CCCCCCCCCCCCCCC | 9.14 | 22555962 | |
524 | Phosphorylation | RVTEAPCYPGAPSTE CCCCCCCCCCCCCCC | 12.02 | 28464451 | |
529 | Phosphorylation | PCYPGAPSTEASGQT CCCCCCCCCCCCCCC | 38.04 | 26074081 | |
530 | Phosphorylation | CYPGAPSTEASGQTG CCCCCCCCCCCCCCC | 34.21 | 28464451 | |
533 | Phosphorylation | GAPSTEASGQTGPQE CCCCCCCCCCCCCCC | 25.79 | 26074081 | |
536 | Phosphorylation | STEASGQTGPQEPTS CCCCCCCCCCCCCCC | 55.12 | 26074081 | |
542 | Phosphorylation | QTGPQEPTSARA--- CCCCCCCCCCCC--- | 33.98 | 23186163 | |
543 | Phosphorylation | TGPQEPTSARA---- CCCCCCCCCCC---- | 26.86 | 29978859 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of TXLNA_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of TXLNA_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of TXLNA_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
NACAM_HUMAN | NACA | physical | 21903422 | |
NACA_HUMAN | NACA | physical | 21903422 | |
TXLNB_HUMAN | TXLNB | physical | 21903422 | |
TBK1_HUMAN | TBK1 | physical | 21903422 | |
TXLNG_HUMAN | TXLNG | physical | 21903422 | |
XRN2_HUMAN | XRN2 | physical | 22939629 | |
UFD1_HUMAN | UFD1L | physical | 22939629 | |
WIPI2_HUMAN | WIPI2 | physical | 22939629 | |
TXLNG_HUMAN | TXLNG | physical | 22939629 | |
TXLNA_HUMAN | TXLNA | physical | 25416956 | |
SPERT_HUMAN | SPERT | physical | 25416956 | |
CE57L_HUMAN | CEP57L1 | physical | 25416956 | |
NSE2_HUMAN | NSMCE2 | physical | 25416956 | |
BRCA1_HUMAN | BRCA1 | physical | 25184681 | |
CUL3_HUMAN | CUL3 | physical | 26344197 | |
DDX17_HUMAN | DDX17 | physical | 26344197 | |
DHX15_HUMAN | DHX15 | physical | 26344197 | |
FUS_HUMAN | FUS | physical | 26344197 | |
PDIA3_HUMAN | PDIA3 | physical | 26344197 | |
RUVB2_HUMAN | RUVBL2 | physical | 26344197 | |
TXLNG_HUMAN | TXLNG | physical | 28514442 | |
TBK1_HUMAN | TBK1 | physical | 28514442 | |
CA122_HUMAN | C1orf122 | physical | 28514442 | |
GFOD2_HUMAN | GFOD2 | physical | 28514442 | |
IFT74_HUMAN | IFT74 | physical | 28514442 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-515, AND MASSSPECTROMETRY. | |
"Large-scale proteomics analysis of the human kinome."; Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.; Mol. Cell. Proteomics 8:1751-1764(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-514, AND MASSSPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-19 AND SER-515, AND MASSSPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-515, AND MASSSPECTROMETRY. | |
"Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis."; Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III; J. Proteome Res. 7:1346-1351(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-18 AND SER-19, AND MASSSPECTROMETRY. | |
"Global proteomic profiling of phosphopeptides using electron transferdissociation tandem mass spectrometry."; Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.; Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-19 AND SER-515, AND MASSSPECTROMETRY. |